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1. Introduction 
For more than 50 years, anterior cervical discectomy and fusion (ACDF) has been the 
workhorse procedure for cervical degenerative pathology. (Bailey & Badgely, 1960; 
Cloward, 1961; Robinson & Smith, 1955)   The procedure has yielded successful results 
clinically in multiple large series. (Bohlman et al, 1993; Gore & Sepic, 1984)  Advances in 
allograft and cage techniques as well as the use of anterior plating systems have diminished 
complications in ACDF. However, concerns about adjacent segment degeneration (ASD) 
have tempered some enthusiasm for the procedure. Gore et al (Gore & Sepic, 1998) reviewed 
a series of 50 ACDF patients followed long term. Almost universally, the patients developed 
ASD. One-third of the cohort developed recurrent pain with half of the symptomatic group 
requiring additional surgery. Hilibrand et al (Hilibrand et al, 1999) evaluated a group of 374 
patients undergoing ACDF. They showed a 2.9% per year risk of development of 
symptomatic ASD, with two thirds of the symptomatic patients requiring additional 
surgery. Goffin et al (Goffin et al, 1995) prospectively followed a series of ACDF patients 
who underwent the procedure for either a degenerative or traumatic condition. Follow-up 
was for five to nine years. Sixty percent of the patients developed ASD, equally distributed 
between the older degenerative population and the younger traumatic population, 
providing evidence that fusion may accelerate degenerative changes. Goffin et al (Goffin et 
al, 2004) reviewed a larger series of ACDF patients followed for an average of 8.3 years. In 
this group, 92% of the patients developed ASD, though they had a much lower rate of 
additional surgical procedures, 6.1% for the entire length of follow-up, distinctly lower than 
Hilibrand et al. Numerous cadaveric biomechanical studies (Eck et al, 2002; Pospiech et al, 
1999) evaluating adjacent level intradiscal pressures and range of motion in simulated 
fusion models have shown that both increase after fusion. These altered biomechanics may 
thus accelerate ASD. 
Against this background, centers began experimenting with cervical disc arthroplasty in the 
1980s. Cummins and collaborators at the Frenchay Hospital, Bristol, England developed a 
metal-on-metal ball and socket arthroplasty and implanted it on a small series of patients in 
the 1990s. (Cummins et al, 1998) The arthroplasty underwent a number of design changes and 
is now known as Prestige. Bryan, in the US, developed a one piece metal-on-polymer device 
called the Bryan Cervical Disc Replacement, initially evaluated clinically in Europe. (Goffin et 
al, 2002) ProDisc-C arthroplasty is a metal-on-polyethylene implant adopted from the ProDisc-
L lumbar disc arthroplasty developed by Thierry Marnay. (Delamarter & Pradhan, 2004)  Since 
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these first three devices have been developed, the number of cervical disc arthroplasties has 
proliferated. The literature in this nascent field is limited, but growing each year.  
2. Types of cervical disc arthroplasty 
It is beyond the scope of this chapter to catalogue all of the cervical disc arthroplasties 
available; the devices with the most clinical experience will be discussed. 
2.1 Prestige 
The technology from the early designs of Cummins et al was acquired by Medtronic 
Sofamor Danek (Memphis, Tennessee) and rebadged Prestige. With Prestige I, the initial ball 
and socket design which was entirely fabricated from stainless steel, was converted to a ball 
and trough design, allowing limited translation. The anterior flanges were diminished in 
size and a locking screw added to prevent bone screw backout. Prestige II was further 
modified by again reducing the anterior flange and modifying the endplates to allow bone 
ingrowth. Prestige ST was the design evaluated in the United States as part of the Food and 
Drug Administration (FDA) investigational device evaluational (IDE) study. This 
arthroplasty incorporates the features of Prestige II with further shortened anterior flanges. 
The final design is Prestige LP, a major change from its predecessors. Instead of stainless 
steel, the Prestige LP is made from a titanium ceramic composite, preserving the ball and 
trough bearing design. It has a titanium plasma spray on the endplates for bone ingrowth, 
as well as two pairs of rails allowing immediate fixation. The flange and locking bone 
screws have been removed. The Prestige LP, being made of titanium, has a better 
compatibility than stainless steel in MRI imaging. (Figure 1) 
 
Bristol/Cummins
PRESTIGE ® I
PRESTIGE® II
PRESTIGE® ST
PRESTIGE® STLP
PRESTIGE® LP
1991 1998  1999 2002 2003 2004
 
(Courtesy of Medtronic Sofamor Danek, Memphis, Tennessee) 
Fig. 1. Prestige Cervical Disc evolution  
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2.2 Bryan Cervical Disc Prosthesis  
Bryan Cervical Disc Prosthesis (Medtronic Sofamor Danek, Memphis, Tennessee) consists of 
a nucleus made of polyurethane between two titanium alloy endplates in a clamshell 
configuration. (Figure 2)  There are two bearing surfaces in the arthroplasty at the interfaces 
between the nucleus and the endplates. A polyurethane sheath attaches to the endplates and 
surrounds the nucleus. Sterile saline is injected between the outer sheath and the nucleus as 
lubricant. The endplates have a titanium porous coating for bone ingrowth and a small 
flange anteriorly to prevent posterior migration. 
 
 
(Courtesy of Medtronic Sofamor Danek, Memphis, Tennessee) 
Fig. 2. Bryan Cervical Disc Prosthesis  
2.3 ProDisc-C  
ProDisc-C Cervical Disc Prosthesis (Synthes, West Chester, Pennsylvania) has a ball and 
socket design, with endplates made of a cobalt-chrome alloy. The endplates have keels for 
immediate fixation and titanium plasma spray backing for bone ingrowth. The bearing 
surface has an articulating dome of ultra high molecular weight polyethylene (UHMWPE) 
attached to the inferior endplate and a concave polished socket integral to the superior 
endplate. (Figure 3)  
 
 
(Courtesy of Synthes, West Chester, Pennsylvania)   
Fig. 3. ProDisc-C Cervical Disc  
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2.4 Porous-Coated Motion (PCM) Cervical Arthroplasty  
The Porous-Coated Motion (PCM) Cervical Arthroplasty (Cervitech, Rockaway, New 
Jersey) consists of two cobalt-chrome-molybdenum (CoCrMo) endplates that have a 
titanium calcium phosphate porous coated backing for bone ingrowth. The device is 
inserted by a “press-fit” method, but the endplates have transverse serrated rows of teeth 
that resist migration. The bearing surface is an ultra high molecular weight polyethylene 
(UHMWPE) convex insert of large radius of curvature attached to the inferior endplate 
which articulates with the polished CoCrMo concave surface of the superior endplate. 
(Figure 4)  
 
 
(Courtesy of Paul McAfee, MD) 
Fig. 4. Porous Coated Motion (PCM) Cervical Arthroplasty 
3. Biomechanics 
Cervical disc arthroplasty attempts to replicate the normal kinematics of the subaxial 
cervical spine, defined as the segments from C3 to C7. The subaxial cervical spine 
contributes 60% of the flexion/extension motion of the cervical spine with each segment 
accounting for between 14 to 22 degrees of motion (Dvorak et al, 1993; Dvorak et al, 1991; 
Penning, 1978). The flexion/extension arc, together with translational movements due to 
slight relative facet motion, results in coupled motions. Coupled motions also occur with 
lateral bending and thus axial rotation. These coupled motions result in differences in the 
center of rotation of each motion segment. Since the center of rotation is not fixed, there are 
instantaneous centers of rotation. (ICR)  Penning (Penning, 1978) established normalized 
ICR for each segment, which were further defined by Amevo et al (Amevo et al, 1991)  The 
normalized ICR for each segment are shown in figure 5 (Bogduk & Mercer, 2000) and are 
grossly posterior and inferior to the center of the caudal vertebral endplate. Arthroplasty 
designs with a ball and socket articulation have a predetermined center of rotation (ie: 
ProDisc-C). These more constrained designs have to be implanted more precisely to match 
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the physiologic center of rotation to avoid increased strain on the facet joints. (Darden & 
Raposo, pending)  
 
 
(Reprinted from: Bogduk N, Mercer S. Clin Biomechanics, 2000) 
Fig. 5. Mean instantaneous axes of rotation for each motion segment of the cervical spine 
depicted with a dot. Two standard deviation range of distribution is located within the 
enclosed circles shown.  
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Fig. 6-A. 
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Fig. 6-B. 
Fig. 6-A, B. AP and lateral radiographs of ProDisc-C 
In the cervical spine, the dominant plane of motion is sagittal. Constraint is therefore 
defined as limitation of anterior-posterior translational motion. (Huang et al, 2003)  An 
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unconstrained arthroplasty would allow unrestricted motion while a fully constrained 
arthroplasty would allow only flexion/extension without any anterior-posterior translation. 
However, compared to large joints, the differences in constraint in cervical disc 
arthroplasties are limited. (Darden & Raposo, pending) (Table 1)   
 
Implant Bryan® Prestige ST® Prodisc-C® PCM-V®
Manufacturer Medtronic Sofamor Danek, Medtronic Sofamor 
Danek
Synthes Cervitech
Bearing surface 
materials
Metal-on-poly; Titanium 
end plates, polycarbonate 
urethane nucleus
Metal-on-metal; Stainless 
steel
Metal-on-poly; Chrome 
cobalt, UHMWPE
Metal-on-poly; chrome 
cobalt, UHMWPE
Bearing surface 
geometry
Biconvex nucleus 
articulating with upper and 
lower endplates
Ball and trough design Ball and socket design Ball and socket design
(shallow sphere)
Primary (immediate) 
fixation
Milling technique creates 
concave endplate surfaces to 
fit convex endplates of the 
device.
Anterior flanges with 
screws
Keels LP: Press-fit, ridges
Degree of constraint Unconstrained Semi-constrained Semi-constrained Semi-constrained
Relative constraint Least Less Most Less
Implant center or 
rotation
Variable; lies at center of 
the mobile nucleus
Variable; superior to disc 
space
Fixed; inferior to disc 
space
Variable; inferior to disc 
space
 
Table 1. Summary of implant features and design characteristics. 
A number of arthroplasties have been evaluated biomechanically versus simulated fusion in 
human cadaveric models. These routinely show increased adjacent segment motion and 
increased adjacent segment disc pressures in the fusion simulations compared to cervical 
disc arthroplasty. (DiAngelo et al, 2003; Dmitriev et al, 2005)   
4. Clinical results 
As a result of the US FDA IDE studies, there have been a number of thorough clinical 
evaluations of cervical disc arthroplasty. These trials have been designed as non-inferiority 
studies, comparing cervical disc arthroplasty to ACDF. The Prestige ST results at two years 
follow-up were reported by Mummaneni et al. (Mummaneni et al, 2007)   The study, similar 
to all of the FDA IDE studies, was a prospective, randomized, multicenter trial comparing 
Prestige ST cervical disc arthroplasty to ACDF for one level pathology. Five hundred forty-
one patients were enrolled with 1:1 randomization; over 75% of patients were available for 
two-year follow-up. There were no statistically significant differences in the revision 
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surgeries at the index level (3.4% ACDF, 1.9% Prestige ST). However, the rate of surgery at 
adjacent levels was statistically higher for ACDF (3.4% versus 1.1%, p=0.0492). Neurological 
success, defined as maintenance or improvement in the neurological exam, was better with 
Prestige ST (92.8%) than ACDF (84.3%). Clinically, the patients were evaluated by Short-
form 36 (SF-36), Visual Analogue Scale (VAS) and the Neck Disability Index (NDI). While 
both groups improved significantly from the preoperative state, there was no statistically 
significant difference between the groups at final follow-up. Overall success was defined as 
an NDI improvement ≥ 15 points, maintenance of the neurological status and the absence of 
implant-related adverse events. The arthroplasty group showed overall success in 79.3% of 
the patients compared to 67.8% in the ACDF group. As a sidebar, the Prestige ST patients 
were able to return to work on average at 45 days postoperatively, compared to 61 days for 
the ACDF patients. 
A small prospective study compared results for Prestige LP and ACDF at a minimum of two 
years follow-up. Single and multilevel procedures were evaluated by VAS, NDI, SF-36 and 
Japanese Orthopedic Association scores. Clinically, while both groups improved 
significantly, there was no statistical difference between them. Motion was preserved in the 
Prestige LP group at a mean of 13.9° on flexion/extension lateral radiographs of two years. 
(Peng et al, 2011)   
For the Bryan Cervical Disc Replacement, Goffin et al reported on the European 
experience, a multicenter, prospective, nonrandomized study, including both single-level 
and multi-level implants. Ninety-eight patients were evaluated at the 4 to 6 year follow-
up point, 89 single-level patients and 9 two-level patients. The patients maintained 
improvement clinically at all evaluation periods. Approximately 90% of the patients had 
good or excellent results by Odum’s criteria. The success rate for the arthroplasties, 
estimated by Kaplan-Meier analysis was 94% at 7 years postoperatively. One patient had 
removal of the arthroplasty for progressive spinal cord compression due to posterior 
osteophytes. (Goffin et al, 2010) 
The Bryan FDA IDE study results at two years were published by Heller et al (Heller et al, 
2009). Four hundred sixty-three patients enrolled, with 242 having a single-level Bryan 
Cervical Disc Replacement and 221 having single-level ACDF. The Bryan patients had 
statistically significantly improved NDI and VAS scores compared to the ACDF group at 
two years follow-up. Other clinical parameters improved equally between the two groups. 
Overall success at final follow-up was better in the Bryan patients (82.6%) versus the ACDF 
controls (72.7%), (p=0.010). As with the Prestige IDE patients, the Bryan patients returned to 
work sooner than did the ACDF patients. 
Riew et al (Riew et al, 2008) evaluated a subset of patients enrolled in the Prestige ST or 
Bryan IDE studies that were determined to have a cervical myelopathy, defined as being 
hyperreflexic, having clonus or having a Nurick grade ≥ 1. In most of the patients, the 
cause of the myelopathy was a disc herniation. Because of enrollment criteria, multilevel 
cervical disease or patients with ossification of the posterior longitudinal ligament (OPLL) 
were excluded. A total of 107 patients in both studies were deemed myelopathic and 
underwent cervical disc arthroplasty. Compared to the ACDF patients, arthroplasty 
patients with myelopathy showed similar clinical improvement. There were no 
arthroplasty patients who deteriorated neurologically, suggesting that myelopathy 
confined to a single disc level without OPLL or retrovertebral osteophytes can be treated 
successfully with cervical disc arthroplasty.  
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Murrey et al (Murrey et al, 2009) published the two year ProDisc-C IDE study. The study 
was structured similarly to the Prestige ST and Bryan studies, with 209 patients enrolled, 
103 who underwent ProDisc-C arthroplasty and 106 who had an ACDF. Both groups 
showed improvement by all clinical after parameters; NDI, SF-36, VAS arm and neck pain 
scores and neurological success. A significant difference was in the rate of re-operation:  
8.5% in the ACDF group versus 1.8% in the ProDisc-C group (p= 0.033). 
Delamarter et al further evaluated the ProDisc-C IDE patients as well as 136 patients who 
received ProDisc-C in the continued access phase of the study, with a minimum of four 
years follow-up. (Delamarter et al, 2010)  Demographic data remained similar between the 
arthroplasty and ACDF groups. All clinical parameters improved equally in both groups at 
all follow-up periods (p<.0001). A significant difference in the study was the rate of 
secondary surgical procedures. At the four year follow-up point, 12 (11.3%) of the ACDF 
patients had additional surgery, while only three (2.9%) of the ProDisc-C patients required 
further procedures (p=.0292). The ACDF patients primarily required additional surgery for 
pseudoarthrosis at the index level; however, six (5.6%) ACDF patients had surgery at an 
adjacent level. Three ProDisc-C patients were converted to fusion for axial pain. No ProDisc-
C patients had to have surgery at adjacent levels. In the continued access arm of the study, 
one ProDisc-C patient required additional surgery to reposition the implant and two were 
converted to fusion for axial neck pain. 
Pimenta et al (Pimenta et al, 2007) prospectively evaluated patients undergoing the PCM 
cervical disc replacement. Seventy-one single-level and 69 multi-level arthroplasties were 
performed. While both groups improved, the multi-level patients showed improved scores 
compared to the single-level patients. The mean NDI improvement was better in the multi-
level PCM group (p=0.021). While the overall IDE results have yet to be reported, Philips et 
al (Phillips et al, 2009) showed in a small set of the IDE patients that arthroplasty was viable 
at levels adjacent to a prior fusion.  
5. Radiographic results 
Heterotopic ossification (HO) has initially been reported in the Bryan Cervical Disc 
Replacement (Bartels & Donk, 2005; Leung et al 2005; Solas et al, 2005) but as the literature 
expands, no disc arthroplasty has proven immune to this problem. (Figure 7) McAfee et al 
characterized the severity of HO with a simple scale, modified from lumbar disc 
arthroplasty findings. The scale ranged from grade 0 (no HO) to grade IV -(complete 
ankylosis). (McAfee et al, 2003)  (Table 2)  Delamarter et al described three patients that 
developed grade IV HO in the ProDisc-C IDE study by 24 months, with two additional 
patients developing grade IV HO by 48 months. Non-steroidal anti-inflammatory drugs 
(NSAIDs) were not part of the study protocol. Interestingly in the continued access arm of 
the study, in which NSAIDs were more commonly used, no patients developed ankylosis at 
the index level. (Delamarter et al, 2010)  Mehren et al (Mehren et al, 2006) evaluated the rate 
of HO at two centers performing cervical disc arthroplasty. Approximately one third of 
patients postoperatively showed no sign of HO, while almost 20% of patients had HO that 
lead to restrictions in motion. Nine percent of the patients had grade IV HO, with most of 
the patients having had multilevel procedures. There was a difference in the overall rate of 
grade IV HO between the two centers, 12.8% versus 5.2%. The center with the lower HO  
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Fig. 7. Lateral flexion radiography- implanted ProDisc-C with heterotopic ossification, 
preserved motion.  
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rate routinely prescribed NSAID use postoperatively. Yi et al (Yi et al, 2010) studied the rate 
of HO according to the arthroplasty type. They found the following HO rates:  Bryan  21.0%, 
Mobi-C (LDR Medical, Troyes, France) 52.5% and ProDisc-C 71.4%. The only two patients 
that developed grade IV HO were in the Bryan group. All patients routinely received 
postoperative NSAIDs.  
 
____________________________________________________________________________ 
 
Grade 0       No HO present 
Grade I       HO is detectable in front of the vertebral body but not in the  
                     anatomic interdiscal space 
Grade II      HO is growing in to the disc space. Possible affection of the 
                     function of the prosthesis 
Grade III     Bridging ossifications which still allow movement of the  
                     prosthesis 
Grade IV     Complete fusion of the treated segment without movement   
                     in flexion/extension 
_____________________________________________________________________________  
 
HO indicates Heterotopic ossification 
_____________________________________________________________________________ 
(modified from McAfee et al, 2003) 
Table 2. Characterisation of the Different Grades of Heterotopic Ossification (HO) in Total 
Cervical Disc Replacement  
In all the clinical studies evaluating cervical disc arthroplasty and HO, there has been no 
correlation between the development of HO and the clinical results. Barbargallo et al 
(Barbargallo et al, 2010) specifically looked at this aspect of cervical disc arthroplasty. They 
found an overall rate of HO development of 42% and no difference in the functional scores 
in patients with or without HO. Segmental range of motion of ≥ 3° was preserved in 93.8% 
of patients with HO. 
6. Complications 
All of the large clinical series published on cervical disc arthroplasty have not reported any 
severe neurological injuries, such as quadriplegia. The rate of revision surgery at the index 
level has been acceptably low. None of the cervical disc arthroplasty series have had 
implants removed for infection. 
Concerns of wear debris and local and remote inflammatory changes in cervical disc 
arthroplasty have been expressed. In vitro wear tests have been submitted to the United 
States FDA as part of the clinical approval process. Generally, wear debris volume has 
been in the range of 10% of that produced by large joint arthroplasties. Anderson et al 
(Anderson et al 2004) published in vitro wear testing on the Bryan Cervical Disc 
Replacement using a custom cervical spine simulator on six disc assemblies. At 10 million 
cycles, the mean mass loss was 1.76% and a mean height loss of 0.75%. At 40 million 
cycles there was an 18% mass loss. Wear particles were elliptical in shape and larger than 
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typical particles in large joint arthroplasties. Anderson studied local and remote wear 
debris and the subsequent inflammatory response using an in vivo caprine model with 
implanted Bryan arthroplasties. Sacrificed animals at up to twelve months showed an 
increase in extracellular wear debris. No apparent inflammatory response was seen locally 
or distally in these animals. 
Clinically, there have been scattered case reports of osteolysis after cervical disc arthroplasty 
implantation. Tumialan and Gluf reported on a 30-year-old man who underwent a ProDisc-
C arthroplasty at C5-6. (Tumialan & Gluf, 2011)  He had an uneventful postoperative course 
until he developed worsening neck pain at nine months. Repeat imaging studies by 15 
months showed a progressive osteolysis process in the vicinity of the superior endplate and 
keel. Work-up for infection was negative. The patient underwent explantation of the 
arthroplasty and conversion to a fusion. The implant was studied after removal and no 
defects or unusual wear was noted. The authors hypothesized that the most likely cause of 
the osteolysis was an immune mediated process. Longer study periods are needed to 
determine the significance of wear changes and the rate of osteolysis of cervical disc 
arthroplasty.  
7. Conclusions 
Cervical disc arthroplasty has been one of the most closely scrutinized surgical procedures 
in the last decade. Short-term prospective clinical studies show cervical disc arthroplasty to 
be at least the equivalent of ACDF for degenerative pathology. There is some evidence that 
cervical disc arthroplasty may play a role in diminishing adjacent segment disease. 
However, the long-term efficacy and safety of cervical disc arthroplasty await further 
clinical studies. 
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